Normal germ cell development
Germ cells (GCs) are the progenitor cells of sperm and oocytes, which are a prerequisite for the development of new life. GC development is initiated early during embryogenesis. In mice, few cells of the proximal epiblast acquire GC competence by BMP2, BMP4 and BMP8B stimuli (Hayashi et al. 2007) . These primordial germ cell (PGC) precursors escape the somatic differentiation program and are specified by upregulation of PRDM1/BLIMP1, PRDM14 and Fragilis (Hayashi et al. 2007 . The PGCs migrate along the developing hindgut to the genital ridges, which eventually differentiate into testes or ovaries. During this migration, PGCs undergo crucial changes, like a G2-arrest, global DNA demethylation and erasure of imprinted genes as shown in mice and partially for humans (Saitou & Yamaji 2012 , Meyenn & Reik 2015 .
After arrival in the genital ridge, the GCs undergo a transition, which prepares them for meiosis. This phase is denominated 'licensing' and is controlled by the RNAbinding protein DAZL (deleted in azoospermia like) (Lin et al. 2008) . In the C57/Bl6 strain of mice, it was shown that DAZL-deficient PGCs migrate to the gonad, but fail to respond to feminizing or masculinizing cues leading to a failure of oogenesis or spermatogenesis respectively (Gill et al. 2011) .
As observed in mice, male sexual differentiation is initiated by the Sry gene (sex determining region on the Y chromosome), which triggers the expression of Sox9 and therewith Sertoli cell differentiation that is essential for proper testis development (Kashimada & Koopman 2010) . In females, ovarian development is supported by inhibition of the SOX9 signaling cascade via beta-catenin and FOXL2, respectively (Kashimada & Koopman 2010) . The expression of CYP26B1, a member of the cytochrome p450 family, prevents developing male embryonic germ cells from a premature initiation of meiosis (Koubova et al. 2006 , Kumar et al. 2011 .
Data dealing with the molecular mechanisms leading to PGC specification in humans are scarce. However, studies have demonstrated that human and murine germ cells display a highly similar expression profile like OCT3/4, NANOG, BLIMP1 and TFAP2C. However, two main differences have been reported so far. Using 'in vitro' differentiation protocols, SOX17 was identified as a key player of human PGC fate inducing PRDM1 expression and downstream GC genes (Irie et al. 2015) .
Vice versa, human PGCs lack the expression of the pluripotency marker SOX2, which is expressed in murine PGCs aside with OCT3/4 and NANOG (Perrett et al. 2008) . Further, PRDM14, which is essential for murine PGC maintenance, shows only low levels of expression in human PGC-like cells and seminomatous TCam-2 cells, which also share a similar gene expression profile with PGCs (Irie et al. 2015 , Nettersheim et al. 2015 , Sugawa et al. 2015 , Tang et al. 2015 .
In human males, undifferentiated GCs (A darkspermatogonia), which are discussed to be the testicular stem cells, settle down at the basement membrane of the developing seminiferous tubules (Clermont 1966) . They give rise to A pale -spermatogonia, which divide mitotically and differentiate into B-spermatogonia (de Rooij 2001). These diploid B-spermatogonia eventually initiate meiotic divisions of spermatogenesis. In a step-wise process, four haploid spermatids are formed out of each diploid B-spermatogonium. Accordingly, self-renewing testicular stem cells in mice are described as A singlespermatogonia, which progress into A paired -and A alignedspermatogonia (de Rooij 2001). The differentiation into mitotically active A 1 -A 4 spermatogonia marks the entry into spermatogenesis, giving rise to B-spermatogonia (de Rooij 2001) . With the onset of puberty and increased retinoic acid (RA) signaling, B-spermatogonia develop into spermatocytes that undergo meiotic divisions to generate haploid spermatids (Bowles & Koopman 2007) . These spermatids enter the process of spermiogenesis/ spermatohistogenesis, putatively involving genes like AEP1, GOPC, PICK1, MNS1 and TAF7L (Yao et al. 2002 , Luk et al. 2006 , Xiao et al. 2009 , Zhou et al. 2013 . Finally, the majority of histones are replaced by protamines resulting in DNA hypercondensation (Balhorn 2007) . Development of the flagellum and the acrosome gives sperm cells their characteristic morphology, necessary for full functionality, i.e. motility and penetration of the egg respectively.
Germ cell malignancies
Germ cell tumors (GCTs) are subdivided into different types (I-V), depending on cell of origin, sex of the patient, age of diagnosis, growth/differentiation behavior and morphology (Oosterhuis & Looijenga 2005) .
Type I GCTs occur during early childhood and present mainly as non-seminomas (embryonal carcinomas (EC), teratomas and yolk-sac tumors). They are thought to originate directly from a PGC or gonocyte and, therefore, do not contain the precursor lesion germ cell neoplasia in situ (GCNIS) (Fig. 1A) .
Type II GCTs arise via a GCNIS (also referred to as: carcinoma in situ (CIS); intratubular germ cell neoplasia unclassified (IGCNU)) (Fig. 1A) (Berney et al. 2016) . Although not formally proven, the generally accepted hypothesis is that GCNIS cells represent arrested PGCs, which had acquired genetic or epigenetic aberrations (Skakkebaek et al. 1987 , Hoei-Hansen et al. 2005 (Fig. 1A) . Morphologically, GCNIS cells resemble PGCs, i.e. they appear round with a big, round nucleus and a clear cytoplasm and grow uniformly within the confines of the seminiferous tubules. GCNIS and PGCs further share a similar gene expression profile, i.e. expression of pluripotency-related genes LIN28, OCT3/4 and NANOG as well as PGC markers PRDM1/BLIMP1, TFAP2C and cKIT (Fig. 1B) . Within 5 (50% of cases) to 7 (70% of cases) years, GCNIS lesions eventually develop into a seminoma or a non-seminoma (Fig. 1A ) (Giwercman & Skakkebaek 1993) .
Seminomas are considered to be the default developmental pathway of GCNIS, since they show only limited differentiation abilities (Oosterhuis & Looijenga 2005 , de Jong et al. 2008 . Like GCNIS and PGCs, seminoma cells display a big round nucleus and a clear cytoplasm, but appear more polygonal in shape. They further share the gene expression profile of PGCs, expressing the pluripotency markers LIN28, OCT3/4 and NANOG and the germ cell markers PRDM1, cKIT, TFAP2C as well as PLAP. In addition, they express SOX17 and D2-40 (Fig. 1B) . The non-seminomas initially present as ECs and display features of totipotency: They are able to differentiate into all three germ layers (meso-, endo-, ectoderm) as well as extraembryonic tissues, thereby giving rise to teratomas, yolk-sac tumors and choriocarcinomas (Oosterhuis & Looijenga 2005) (Fig. 1A) . ECs share expression of TFAP2C (variable), GDF3 (high in EC), DPPA3 (high in EC), OCT3/4 and NANOG with seminomas and/or GCNIS, but additionally express DNMT3B, DNMT3L, NODAL, CRIPTO, CD30 and SOX2 (Hoei-Hansen et al. 2004 , Almstrup et al. 2005 , Ezeh et al. 2005 , de Jong et al. 2008 (Fig. 1B) . Furthermore, ECs show only weak to absent expression of cKIT as well as cytoplasmic localization of PRDM1 (Rajpert-De Meyts & Skakkebaek 1994 , Leroy et al. 2002 , Almstrup et al. 2005 , Eckert et al. 2008 (Fig. 1B) . Outside the testis, type II GCTs are found mainly along the body mid-line, the thymus and the brain (Utz & Buscemi 1970 , Johnson et al. 1976 , Bassetto et al. 1995 , Oosterhuis & Looijenga 2005 .
Common to the vast majority of GCTs is an amplification of the short arm on chromosome 12 (12p gain), mainly caused by isochromosome formation (Rosenberg et al. 1998 , Oosterhuis & Looijenga 2005 (Fig. 1B) . So far, 12p gain was detected predominantly in invasive GCT samples. Therefore, it is believed that amplification of this chromosomal region occurs during invasive growth of GCTs (Rosenberg et al. 2000 , Summersgill et al. 2001 . Nevertheless, amplification of 12p was also detected in some GCNIS cases in tubules adjacent to tumors, when the invasive process likely has begun (Ottesen et al. 2003) . Since the amplified region on chromosome 12 encodes for the pluripotency-and PGC-related genes NANOG, GDF3 and DPPA3 (Ezeh et al. 2005) , gain of these genes might contribute to the invasive capacities of GCTs.
Type III GCTs, the spermatocytic tumor are detected in the 5th-6th decade of life and are a rare GCT (<1% of testicular tumors) (Looijenga & Oosterhuis 1999 , Oosterhuis & Looijenga 2005 , Raiss et al. 2011 (Fig. 1A) . It is hypothesized that spermatocytic tumors originate from germ cells that are capable of maturing at least to spermatogonia/pachytene spermatocytes, since these GCTs express typical pachytene spermatocyte markers like SCP1, XPA and SSX (Aggarwal & Parwani 2009) . Screening for oncogenic driver mutations in spermatocytic tumors revealed genetic aberrations in the FGFR3 and HRAS gene (Goriely et al. 2009 ). Goriely and coworkers demonstrated by parallel sequencing of sperm DNA that occurrence of these mutations increases with paternal age, arguing for a category of the so-called paternal age effect mutations (Goriely et al. 2009 ). These mutations are thought to occur in spermatogonia. Owing to the proliferative capacities of the FGFR3-and HRAS-involved signaling pathways, it is believed that these mutations then selectively become enriched during clonal expansion of spermatogonia (Goriely et al. 2009 ). Spermatocytic tumors typically consist of three cell types: small, medium and large size, which morphologically resemble spermatogonia or spermatocytes with round and sometimes multinucleated nuclei (Oosterhuis & Looijenga 2005) . As in type I GCTs, GCNIS cells are not present in spermatocytic tumors (Aggarwal & Parwani 2009 ). Spermatocytic tumors are negative for classical seminoma or EC markers, like PLAP, OCT3/4 and CD30, but sometimes positive for cKIT and VASA (Oosterhuis & Looijenga 2005 , Aggarwal & Parwani 2009 ). In contrast to classical seminomas and other type II GCTs, spermatocytic tumors display gain of chromosome 9 or X, but show no isochromosome 12p formation (Rosenberg et al. 1998 , Verdorfer et al. 2004 , Reuter 2005 .
Type I and type II GCTs: results of a flawed licensing
As mentioned, after specification, PGCs initiate the expression of germ cell and pluripotency markers. After arrival of the PGCs in the genital ridge, they prepare for gametogenesis; this stage is called 'licensing' (Gill et al. 2011) . During licensing, the genes Dazl, Ddx4 and Dmrt1 are induced and repress the PGC-specific genes and the pluripotency markers. This is evident in Dazl mutants, where expression of pluripotency markers persists and the germ cells eventually initiate apoptosis (Lin & Page 2005) . Interestingly some of the gonadal cells in Dmrt1 mutants, as well as in animals heterozygous for Tfap2c and Nanos3 also fail to downregulate pluripotency markers after arrival in the genital ridge in the 129 genetic background (Krentz et al. 2013 , Schemmer et al. 2013 . In these mutants, the persistence of Nanog and Oct3/4 as well as other PGC and pluripotency marker genes like Dnd1, Prdm14, Lin28, cKit and Dppa3 counteracts apoptosis leading to rapid development of a germ cell tumor equivalent to a type I GCT, an early childhood tumor (Kehler et al. 2004 , Western 2009 , Pirouz et al. 2012 . These data in mice suggest that interference with genes involved in downregulation of the pluripotency genes after arrival in the genital ridge is a critical (and error-prone) step. According to these findings, human type I germ cell tumors might be initiated during licensing, when arriving PGCs downregulate the PGC-specific genes but fail to downregulate the pluripotency markers. A similar mechanism might apply to extragonadal GCTs (germinomas and non-germinomas). There, misrouting of the cells prevents them from entering the genital ridge. The cells eventually initiate apoptosis, since they are deprived of their growth and guidance factors. The misrouted GCs are not confronted with the somatic cells of the genital ridge and never encounter the crosstalk leading to initiation of the licensing cascade. If they survive and persist, they might give rise to extragonadal GCTs.
Similar to Type I GCTs, the pre-GCNIS and the GCNIS of the type II GCTs is also initiated at licensing. Here, the arriving PGCs not only maintain expression of the pluripotency genes, but also retain expression of SOX17, PRDM1 and PRMT5 (Eckert et al. 2008) . Recent data indicate that in humans, SOX17 is a critical determinant of PGC fate transactivating expression of PRDM1 (Irie et al. 2015) . In turn, PRDM1 and PRMT5 proteins cooperate to establish a symmetric dimethylation at arginine 3 of histones H2a and H4 (H2a/H4R3me2s), leading to suppression of somatic differentiation (Ohinata et al. 2005 , Ancelin et al. 2006 . Since such cells remain as undifferentiated GCNIS in the developing testicular environment for years, we speculate that the SOX17-PRDM1 cascade not only blocks further differentiation along the germ cell fate but also maintains a survival signal and renders the cells in proliferative dormancy.
Therefore, these data indicate that 'licensing' is a critical step in germ cell biology where the pluripotency and the PGC program must be suppressed for proper germ cell development to proceed.
Germinoma: misrouting of germ cells by defects in cKIT or CXCR4
Type II GCTs can also be found in thymus and brain, where they are termed germinoma (Oosterhuis & Looijenga 2005) . It is assumed that intracranial germinomas, which are highly similar to the histology of seminomas arise from PGCs that failed to enter the genital ridges during embryogenesis. PGCs positive for the receptor tyrosine kinase cKIT migrate along an SCF gradient to the genital ridges (Runyan et al. 2006 , Gu et al. 2009 . After arrival at the developing gonadal site, cKIT expression is downregulated. Therefore, it is conceivable that auto-activating mutations of the cKIT gene (exon 17: D816V, D816H, N822K, Y823D; exon 11: L576P, W557C), rendering cKIT expression independent of SCF, might cause erroneous migration of PGCs, eventually leading to formation of intracranial germinomas (Przygodzki et al. 2002 , Kemmer et al. 2004 , WillmorePayne et al. 2006 , Biermann et al. 2007 ). Sakuma and coworkers and Kamakura and coworkers demonstrated cKIT expression in all germinomas or germinomatous components of mixed non-germinomas (Sakuma et al. 2004 , Kamakura et al. 2006 . Additionally, Sakuma and coworkers found that 25% of all germinomas analyzed harbored an autoactivating cKIT mutation at exon 11 or 17, while Kamakura and co-workers detected mutated cKIT in 23% of germinomas (exon 2 (E73K, T96M), 11 (V560D), 13 (A636V), 17 (D816Y)) (Sakuma et al. 2004 , Kamakura et al. 2006 ). These mutation rates are very similar to the cKIT mutation rates found in classical seminoma (24.1%) (Sakuma et al. 2003 , Kemmer et al. 2004 . Thus, autoactivating cKIT mutations might lead to an SCF-independent migrational path of the PGCs, leading to formation of intracranial germinomas.
An alternative mechanism represents the chemokinemediated CXCR4 pathway, which is activated by selective binding of CXCL12. Increased activity of the CXCR4 pathway correlates to an increased risk to develop metastases and stimulates tumor proliferation, invasiveness as well as angiogenesis (Guan et al. 2015 , Ma et al. 2015 . CXCR4-positive PGCs migrate along somatic sites expressing CXCL12 (Ara et al. 2003 , Molyneaux et al. 2003 , Gilbert et al. 2009 , Takeuchi et al. 2010 . CXCR4-positive GCTs mainly metastasize to sites with CXCL12 expression. Gilbert and coworkers demonstrated that expression of CXCR4 is high in seminomas and in the seminoma cell line TCam-2 compared with normal testis (Gilbert et al. 2009 ). They demonstrated further that TCam-2 cells start to migrate in response to CXCL12, while CXCR4-negative 2102EP cells do not. Since it has been demonstrated that TCam-2 cells cluster close to human PGC-like cells, it seems reasonable to assume that human PGCs use both cKIT and CXCR4/CXCL12 for migration (Irie et al. 2015 , Tang et al. 2015 .
GCT cell lines as model to study germ cell development and malignancy
Several human GCT cell lines have been established in order to generate suitable model systems for in vitro studies: Most of them are derived from ECs and, therefore, share pluripotent or nullipotent characteristics (i.e. 2102EP, NCCIT; Table 1 ). In addition, cell lines have been established from choriocarcinomas (JEG-3, JAR and BeWo; Table 1), resembling differentiated non-seminomas. From seminoma patients, three cell lines have been derived so far, namely TCam-2, JKT-1 and SEM-1 (Table 1) (Mizuno et al. 1993 , Kinugawa et al. 1998 , Russell et al. 2013 . Thorough analyses revealed that TCam-2, but not JKT-1 cells, resemble seminoma in vitro (de Jong et al. 2008 , Eckert et al. 2008 , Nettersheim et al. 2012 , while SEM-1 cells show intermediate characteristics between seminoma and nonseminoma (Russell et al. 2013) .
EC cell lines have long been used as a proxy for embryonic stem cell (ESC) research, owing to their similarities in marker expression, their extended selfrenewal capacities and their ability to differentiate into a wide range of cell types (Thomson 1998 , Chaerkady et al. 2010 , Pera et al. 2000 . Today EC cell lines still represent a valuable in vitro model for studying pluripotency and stem cell regulatory networks particularly in testicular tumors, in order to identify novel targets for GCT therapy.
Seminomas and the seminoma-derived cell line TCam-2 closely resemble PGCs. Like PGCs, TCam-2 cells express pluripotency markers LIN28, NANOG, OCT3/4 and PGC markers PRDM1, TFAP2C, DMRT1 as well as cKIT (Eckert et al. 2008 , Nettersheim et al. 2011a (Fig. 1B) . In humans, PGCs express SOX17 (Campolo et al. 2013) , which is also detected in GCNIS/ seminoma and TCam-2 cells (Irie et al. 2015) (Fig. 1B) .
Using a murine system allowing for differentiation of PGC-like cells from embryonic stem cells (ESCs), Nakaki and coworkers defined a set of 75 genes as 'core' PGC genes (Nakaki et al. 2013) . Meta-analysis of expression microarray analyses demonstrated that many of these genes are also expressed in human GCNIS, seminoma, EC and teratoma tissues as well as TCam-2 cells ( Fig. 2A , B, C and D) (Biermann et al. 2007 , Eckert et al. 2008 . A Venn diagram illustrates that 14 of these 'core' PGC genes are commonly expressed in these samples with an expression intensity threshold ≥Log 2 10, namely cKIT, KLF2, DPPA3, PYGL, TCL1, CKB, BRPF3, SORBS1, KCTD15, HEY1, RGS16, AP3B2, GRHL3 and TDH (Fig. 2E and F) .
Furthermore, a meta-analysis of genome-wide gene expression between TCam-2 and murine male/female PGCs at embryonic developmental days 11.5, 12.5 and 13.5 (data from (Jameson et al. 2012) (expression intensity threshold ≥Log 2 10)) demonstrates that the majority of genes expressed in male or female PGCs are also detectable in TCam-2 cells (n = 1022) (Fig. 3A , B and C). A comparison of these 1022 genes with the gene expression data of GCNIS, seminomas and ECs shows that 690 genes are also expressed in these GCT entities (expression intensity threshold ≥Log 2 10) (Fig. 3D) .
Recently, Irie and coworkers reported that human ES-derived PGC-like cells share a transcriptional profile with TCam-2 seminoma-like cells (Irie et al. 2015). These data point out that PGCs, GCC tissues (GCNIS, seminomas, ECs) and TCam-2 cells are closely related to each other and that TCam-2 cells clearly represent a suitable PGC model in vitro.
In mice, development of GCNIS and seminomas are not observed, but the orthotopical transplantation of TCam-2 cells into the murine seminiferous tubules results in the formation of a GCNIS/seminoma. Thus, this approach represents a valuable strategy for the study of human seminomas in vivo (Nettersheim et al. 2012) (Fig. 1A) .
Taken together, GCT-derived cell lines display a wide variety of phenotypes, from being close to PGC (TCam-2), close to ESC (EC lines) or differentiated in a variety of tissues. Expression of the pluripotency network is detected in seminomas, ECs and derived cell lines. Thus, regulation and timely repression of genes involved in pluripotency appears to be the most critical step in germ cell development.
Regulation of PRDM1 by LIN28 in PGCs and GCTs
In addition to SOX17, PRDM1 levels seem to be controlled by LIN28. Lin28 is a repressor of miRNA let7 (miR-let7) and miR-let7 in turn represses Prdm1. Thus, expression of Lin28 is essential for proper murine PGC development (Newman et al. 2008 , West et al. 2009 ). LIN28 expression is also detectable in GCNIS, seminomas (including TCam-2) and ECs (West et al. 2009 , Nettersheim et al. 2011b . TCam-2 cells differentiate in vitro into a mixed nonseminoma upon stimulation with FGF4, EGF and TGF-b1 (Nettersheim et al. 2011b) ( Fig. 1A) . During this process, LIN28A, but not LIN28B, and PRDM1 are downregulated, accompanied by reduced H2a/H4R3me2s. Knocking down LIN28A in TCam-2 by siRNA suppresses PRDM1 expression, but reduction of PRDM1 leaves LIN28 unaffected (Nettersheim et al. 2011b ). This suggests that in human PGCs, PRDM1 levels are fine-tuned by miR-let7, which in turn is suppressed by LIN28.
DNA (de)methylation in GCs and GCTs
PGCs undergo global DNA demethylation during migration, although running through several rounds of replication in the presence of DNMT1. Additionally, later during migration, they arrest in G2-phase. Thus, an active DNA demethylation process has been assumed (Hajkova et al. 2002 , Saitou & Yamaji 2012 . Hackett and coworkers demonstrated that this active DNA demethylation is driven by members of the Tet hydroxylase family (TET1/2) (Hackett et al. 2013) . TET enzymes oxidize 5-methylcytosine (5mC) to 5-hydroxymethycytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), resulting in activation of the base excision repair (BER) mechanism and in excision as well as replacement of a modified cytosine by an unmodified one (Hajkova et al. 2002 (Hajkova et al. , 2010 . Expression of the TETs (1-3) and the co-keyplayer of active DNA demethylation TDG was detected in GCNIS, seminomas, ECs and corresponding cell lines . In general, 5mC levels are low in GCNIS and seminomas, but high in non-seminomas (Smiraglia et al. 2002 , Netto et al. 2008 , Almstrup et al. 2010 , Wermann et al. 2010 . Nevertheless, the 5mC oxidation products 5hmC, 5fC and 5caC were detectable in all GCT cell lines analyzed and EC tissues . In GCNIS and seminoma tissues, 5hmC correlated to the presence or absence of 5mC levels, while 5fC and 5caC were detectable in all GCNIS/seminoma samples independent of 5mC/5hmC status . In contrast to these data, Kristensen and coworkers found only very low levels of 5hmC and TET1 in GCNIS cells (Kristensen et al. 2014) . Furthermore, they found high expression of APOBEC1, a key player of the deamination pathway of active DNA demethylation and of BER key players like MBD4, APEX1 and PARP (Branco et al. 2012 , Kristensen et al. 2014 . At the end of both pathways of active DNA demethylation, the oxidation and deamination pathway, the BER mechanism catalyzes replacement of a modified cytosine by an unmodified cytosine. Thus, expression of BER keyplayers in GCNIS/GCTs is consistent between published data, but future studies will show which (or if both) pathway(s) of active DNA demethylation is/are active in GCTs.
In adult human testis tissue, persisting 5mC marks were detected throughout all cell types of spermatogenesis, while 5hmC, 5fC and 5caC marks were detectable in spermatogonia, but steadily decreased with progression of spermatogenesis ). These findings point at an active DNA demethylation in spermatogonia, which is turned off upon initiation of spermatogenesis. The authors assume that 5hmC, 5fC and 5caC marks are diluted out with each round of mitosis/meiosis -similarly to a process already described during mouse preimplantation development (Inoue et al. 2011) . Thus, the ability to actively demethylate DNA is maintained during maturation of PGCs to spermatogonia (but not further), development of GCTs and in GCT cell lines.
The pluripotency factor NANOG maintains selfrenewal of undifferentiated cells in concert with OCT3/4 and SOX2 (Chambers et al. 2003) . Human spermatogonia (fetal and adult) as well as seminomas and TCam-2 cells display hypomethylation of the NANOG promoter (0-10% 5mC), which corresponds to high levels of NANOG expression (Nettersheim et al. 2011a) . Hypomethylation of the Nanog promoter was also found in murine PGCs (Seisenberger et al. 2012) . In murine testis tissue and sperm as well as in adult human testis tissue and mature sperm, the NANOG promoter is found hypermethylated (>60-100% 5mC) (Imamura et al. 2006) . At present, we can only speculate that, similar to the murine situation, human PGCs display hypomethylation of the NANOG promoter as well. Therefore, epigenetic silencing of NANOG expression via DNA methylation seems to occur at later stages of germ cell development. In line, expression of NANOG can be detected in human PGCs, but not in mature GCs (Kerr et al. 2008 , Sugawa et al. 2015 .
We speculate that in GCNIS cells, the methylation of the NANOG promoter fails to occur, keeping the gene locus open and accessible for transcription factors, thereby promoting pluripotency and self-renewal.
While failure to methylate (and silence expression) is clearly correlated to malignant aberration, in normal GCs downregulation of NANOG transcription clearly precedes the DNA methylation. Therefore, it seems that failure to methylate the NANOG promoter is not the cause of the malignancy, but rather the consequence.
Screening for GC-and GCT-specific expression of noncoding RNAs
Short noncoding RNAs (sncRNAs) like micro-RNAs (miRNAs) and PIWI-interacting RNAs (piRNAs) play important regulatory roles in many developmental processes, including germ cell development. De Jong and coworkers, Gillis and coworkers and Novotny and coworkers screened for the expression of miRNAs in GCNIS and invasive GCTs as well as fetal and adult testis tissue. In these studies, different groups of miRNAs that specifically distinguish among GCNIS, GCTs and (fetal, adult) testis tissue were identified (Gillis et al. 2007 , de Jong et al. 2008 , Novotny et al. 2012 . For example, the miR146 is underexpressed in seminoma compared with normal testis tissue and putatively targets the PGC marker cKIT (He et al. 2005 , Gillis et al. 2007 . Furthermore, the embryonic germ cell-specific miRNA cluster 371-373 was upregulated in TCam-2 and GCT tissues, acting in conjunction with RAS downstream of P53. Additionally, miRNA cluster 302-367 is expressed in GCNIS, GCTs and fetal gonads (Gillis et al. 2007 , Novotny et al. 2012 ). Novotny and coworkers conclude from these results that the miRNA expression profile changes during testis development and that the miRNA profile of adult testis with GCNIS cells shares characteristic similarities with the expression in fetal gonocytes (Novotny et al. 2012) . McIver and coworkers screened for changes in miRNA expression between postnatal gonocytes and spermatogonia to gain insight into the miRNA processes that influence maturation of gonocytes and might cause GCNIS development (McIver et al. 2012) . They found seven differentially expressed miRNAs (upregulated in spermatogonia vs gonocytes: miR136, -743q and -463; downregulated miR290-5p, -291a-5p, -293 and -294) that are involved in regulation of PTEN and WNT signaling and CyclinD1 (McIver et al. 2012) . The miRNA cluster 290-295 is highly expressed in ESCs and promotes proliferation and pluripotency by maintaining OCT3/4 expression (Zheng et al. 2011) . Therefore, McIver and coworkers believe that downregulation of miRNA cluster 290-295 marks initiation of gonocyte differentiation. Failure in downregulating this miRNA cluster might contribute to GCNIS formation (McIver et al. 2012) .
piRNAs are key players of genome integrity in the developing germ line as they inhibit the activity of transposable elements (Siomi et al. 2011) . Ferreira and coworkers and Rounge and coworkers analyzed the expression of piRNAs and interacting PIWI proteins in GCTs compared with normal testis tissue. These studies revealed a strong downregulation of piRNAs in seminomatous and non-seminomatous GCTs (Ferreira et al. 2014 , Rounge et al. 2015 and silencing of the PIWI genes PIWIL-1, -2, and -4 by DNA methylation (Ferreira et al. 2014) . Since PIWIL-2 is highly expressed in the fetal gonad and during early spermatogenesis to inhibit germline transposons like LINE-1 in concert with mature piRNAs, Ferreira and coworkers believe that the loss of the PIWI/piRNA machinery might play an important role in GCT development (Ferreira et al. 2014) .
The alternative explanation is that the miRNA and piRNA profile detected in GCTs (persistence of expression of miRNAs from early gonocytes and lack to upregulate the piRNAs, which are indicative for germ cell differentiation) are yet another indicator for the arrested GC origin of GCTs as put forward by Skakkebaeck (Skakkebaek et al. 1987) .
The somatic microenvironment determines the fate of TCam-2 cells
TCam-2 cells xenotransplanted orthotopically into the seminiferous tubules of nude mice grow GCNIS/ semi noma-like, while growth in a somatic microenvironment, like the flank or brain, promotes transition into an EC-like state (Nettersheim et al. 2012 (Fig. 1A) . Additionally, cultivation of TCam-2 under culture conditions mimicking a somatic environment, forces differentiation into a mixed non-seminoma (Nettersheim et al. 2011b) (Fig. 1A) . This transition of seminoma to an EC-like phenotype is accompanied by a number of epigenetic and molecular changes: the initial step in this process is the inhibition of BMP signaling by the microenvironment, resulting in de-repression of NODAL signaling (Nettersheim et al. 2015) . During the so-called maturation phase, active NODAL signaling further represses intrinsic BMP signaling by activating LEFTY1/2, CRIPTO/CRYPTIC and ZIC3 (Nettersheim et al. 2015) . This phase is accompanied by an overall increase in de novo DNA methylation and the upregulation of pluripotencyassociated genes (Nettersheim et al. 2015) . Over time, a slow feedback loop re-establishes BMP signaling by activation of WNT3/5B, BMP4/BMP7 and FGF2/19, which stabilizes the acquired EC-like cell fate and results in a balance between NODAL and BMP signaling pathways (Nettersheim et al. 2015) . SOX2 is essential for initiation of the NODAL signaling loop during this reprogramming. Lack of SOX2 results in failure to activate the NODAL signaling key-players LEFTY1/2 and CRIPTO, suggesting that SOX2 is downstream of BMP inhibition but upstream of NODAL activation (Nettersheim et al. 2016) .
This demonstrates that the cellular microenvironment has a profound impact on the cell fate of TCam-2 cells. Since it was demonstrated that TCam-2 closely resemble PGCs (Irie et al. 2015 , Tang et al. 2015 , we speculate that proper PGC development also depends on a crosstalk with the somatic cells from the gonadal microenvironment, i.e. BMP signaling regulating NODAL activity. Factors leading to alterations of this crosstalk might interfere with the tightly controlled repression of pluripotency factors. In this context, the roles of endocrine disruptors might also be important.
Endocrine disruptors as a risk factor for GCT development and testicular dysgenesis syndrome
In Western countries, human sperm count is steadily declining, while the incidence of testicular dysgenesis syndrome (TDS), involving testicular cancer, cryptorchidism and hypospadias, is risingboth indications might be explained by the exposure to hormonally active substances found in our environment (Jensen et al. 1995 , Nilsson 2000 , Skakkebaek et al. 2001 , Nohynek et al. 2013 , Hauser et al. 2015 . Endocrine disruptors (EDs), i.e. phthalates, polychlorinated biphenyls or alkylphenols are small molecules acting like hormones, which can cause adverse health effects (toxicity) via endocrine-mediated mechanisms (Nohynek et al. 2013) . Several studies suggest their negative influence on reproduction by mimicking/modulating of sex hormones that are secreted by the ovaries or testes (Nilsson 2000) . As reviewed by Del-Mazo and coworkers, EDs may adversely affect gene expression levels in PGCs and developing testis (i.e. oxidative stress response) or epigenetic processes in sperm (i.e. by deregulation of epigenetic enzymes) (Wu et al. 2010 , Del-Mazo et al. 2013 . Therefore, exposure of PGCs to EDs may interfere with the downregulation of the PGC-and pluripotency program, leading to increased development of GCNIS or type I GCTs.
Further, Ohlson and coworkers demonstrated a sixfold increased risk for developing seminomas among men exposed to polyvinyl chloride (PVC), the third-most commonly used plastic polymer in the environment (Ohlson & Hardell 2000) .
So, it seems that exposure to EDs in utero could lead to increased rate of PGCs transformed to GCNIS cells, which in adulthood are further triggered by e.g. PVC to progress into a GCT. In this respect, in vitro studies using GCT cell lines, especially TCam-2 could help to get insights into the effects of EDs on gene expression, protein composition and epigenetics of GCs (Del-Mazo et al. 2013) .
Does poised chromatin render germ cells prone to transformation?
According to the theory first described by Skakkebaek, a PGC/gonocyte has failed to differentiate further and remains silent until puberty, where it starts to proliferate giving rise to GCNIS and subsequently seminomas or non-seminomas (Skakkebaek 1972 , Skakkebaek et al. 1987 . Molecular analyses of the past decades in part reviewed here further substantiated this claim.
Recently, several groups found that through the germ line, a very characteristic pattern of histone modifications, the presence of repressive marks (H3K27me3) and active marks (H3K4me3) is detected at key developmental promoters (Hammoud et al. 2009 , Sachs et al. 2013 , Lesch & Page 2014 . This so-called 'poised' chromatin is also detected in pluripotent ESCs and thought to be instrumental for pluripotency (Azuara et al. 2006 , Bernstein et al. 2006 , Mikkelsen et al. 2007 . As a consequence, the mammalian germ line has been described as a pluripotency cycle featuring an epigenetic status, which is primed to rapidly re-activate toti-and pluripotency upon fertilization (Leitch & Smith 2013) .
In light of these findings, we would like to extend the hypothesis of the origin of type II GCTs from Skakkebaek ( Fig. 1A) . While several lines of evidence indicate that a germ cell tumor originates from a 'misinstructed' PGC or early gonocyte, we propose that germline cells from adult mice and humans, which have not initiated meiosis, are also able to give rise to a type II GCT, because these cells are epigenetically prepared to rapidly re-activate totipotency. Therefore, exposure to EDs interfering with the mechanisms and stabilizing this poised state might lead to re-initiation of the pluripotency program, resulting in the formation of a GCNIS or a type I GCT. In fact, stochastic re-activation of the pluripotency program has been demonstrated for gonadal cells from adult mice and humans. They convert to induced pluripotent cells solely by application of appropriate media conditions (Kanatsu-Shinohara et al. 2008 , Ko et al. 2009 , Kossack et al. 2009 , Liu et al. 2011 . Therefore, it seems that germ cells harboring 'poised' histone marks in conjunction with reduced DNA methylation are more than other somatic cells at risk to re-activate the PGC and pluripotency program and, as such, initiate the formation of GCTs.
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